IPO registrations (S-1, F-1) · Registrants
Bionano Genomics, Inc.
- SEC CIK
- 1411690 · filings on EDGAR ↗
- Former names
- BioNano Genomics, Inc (2019–2021); Bionano Genomics, Inc (2019–2021); BioNanomatrix Inc (2007–2011)
- Registration
- Form S-1, first filed 2018-06-28, last 2026-10-27; 6 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 2018-08-22; declared effective 2018-08-20
- Industry (SIC)
- Laboratory Analytical Instruments 3826
- Incorporated in
- DE
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, San Diego, CA 92121
- EIN
- 26-1756290
- Ticker
- BNGO (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Bionano Genomics, Inc. on the corporate pages
Offering terms
- Proposed price range
- $6.00–$7.00 per share (S-1/A filed 2018-08-17)
- Final price
- $6.12 per share, within the range (424B4 filed 2018-08-22, an initial public offering)
- Shares sold
- 3,360,000
- Gross proceeds
- $20,580,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol BNGOU
- Lead underwriters
- Roth Capital Partners
- Syndicate
- Maxim Group; LifeSci Capital LLC
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: BIONANO GENOMICS INC Fuzzy (name and state)
- Form 5500 plan sponsor: BIONANO GENOMICS, INC. EXACT (EIN (EXACT))
- Federal award recipient: BIONANO GENOMICS, INC Fuzzy (name and state)
- Form D issuer: Bionano Genomics, Inc. EXACT (CIK (EXACT))
- SEC filer: Bionano Genomics, Inc EXACT (CIK (EXACT))
- Person page: Christopher J Twomey Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 36
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2018-06-28 | S-1 | S-1 (registration) | BioNano Genomics, Inc | 0001193125-18-207855 ↗ |
| 2018-07-13 | S-1/A | S-1/A (amendment) | BioNano Genomics, Inc | 0001193125-18-217313 ↗ |
| 2018-07-17 | S-1/A | S-1/A (amendment) | BioNano Genomics, Inc | 0001193125-18-219135 ↗ |
| 2018-07-19 | S-1/A | S-1/A (amendment) | BioNano Genomics, Inc | 0001193125-18-220933 ↗ |
| 2018-07-31 | S-1/A | S-1/A (amendment) | BioNano Genomics, Inc | 0001193125-18-232370 ↗ |
| 2018-08-15 | S-1/A | S-1/A (amendment) | BioNano Genomics, Inc | 0001193125-18-249108 ↗ |
| 2018-08-17 | S-1/A | S-1/A (amendment) | BioNano Genomics, Inc | 0001193125-18-251018 ↗ |
| 2018-08-20 | EFFECT | EFFECT (declared effective) | BioNano Genomics, Inc | 9999999995-18-002141 ↗ |
| 2018-08-21 | S-1MEF | S-1MEF (added securities) | BioNano Genomics, Inc | 0001193125-18-253400 ↗ |
| 2018-08-22 | 424B4 | 424B4 (final prospectus) | BioNano Genomics, Inc | 0001193125-18-254422 ↗ |
| 2019-03-29 | S-1 | S-1 (registration) | Bionano Genomics, Inc | 0001193125-19-091058 ↗ |
| 2019-04-17 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc | 9999999995-19-000744 ↗ |
| 2019-09-18 | S-1 | S-1 (registration) | Bionano Genomics, Inc | 0001140361-19-016923 ↗ |
| 2019-10-17 | S-1/A | S-1/A (amendment) | Bionano Genomics, Inc | 0001140361-19-018566 ↗ |
| 2019-10-21 | S-1MEF | S-1MEF (added securities) | Bionano Genomics, Inc | 0001140361-19-018740 ↗ |
| 2019-10-21 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc | 9999999995-19-002355 ↗ |
| 2019-10-23 | 424B4 | 424B4 (final prospectus) | Bionano Genomics, Inc | 0001140361-19-018889 ↗ |
| 2020-03-11 | S-1 | S-1 (registration) | Bionano Genomics, Inc | 0001140361-20-005425 ↗ |
| 2020-03-19 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc | 9999999995-20-000599 ↗ |
| 2020-03-24 | S-1/A | S-1/A (amendment) | Bionano Genomics, Inc | 0001140361-20-006739 ↗ |
| 2020-04-01 | S-1MEF | S-1MEF (added securities) | Bionano Genomics, Inc | 0001140361-20-007747 ↗ |
| 2020-04-01 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc | 9999999995-20-000664 ↗ |
| 2020-04-03 | 424B4 | 424B4 (final prospectus) | Bionano Genomics, Inc | 0001140361-20-007878 ↗ |
| 2020-07-07 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc | 9999999995-20-001703 ↗ |
| 2020-08-25 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc | 9999999995-20-002251 ↗ |
| 2023-05-10 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc. | 9999999995-23-001365 ↗ |
| 2023-11-06 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc. | 9999999995-23-003230 ↗ |
| 2024-06-20 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc. | 9999999995-24-001907 ↗ |
| 2024-08-12 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc. | 9999999995-24-002502 ↗ |
| 2025-01-10 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc. | 9999999995-25-000082 ↗ |
| 2025-09-11 | S-1 | S-1 (registration) | Bionano Genomics, Inc. | 0001140361-25-034651 ↗ |
| 2025-09-16 | 424B4 | 424B4 (final prospectus) | Bionano Genomics, Inc. | 0001140361-25-035138 ↗ |
| 2025-09-16 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc. | 9999999995-25-002981 ↗ |
| 2026-10-27 | S-1 | S-1 (registration) | Bionano Genomics, Inc. | 0001193125-26-434439 ↗ |
| 2026-11-05 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc. | 9999999995-26-003447 ↗ |
| 2026-11-05 | EFFECT | EFFECT (declared effective) | Bionano Genomics, Inc. | 9999999995-26-003457 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-08-17 | S-1/A | registration statement | $6.00–$7.00 | $6.50 | 2,450,000 | $15,925,000 | Nasdaq BNGO | 3 | primary document; range, price sentence, shares headline, proceeds computed, cover names 3 | document ↗ |
| 2018-08-22 | 424B4 | final prospectus | $6.12 | 3,360,000 | $20,580,000 | Nasdaq BNGOU | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BARKER DAVID L | Director | 13 | 2018–2026 | ||
| BLAIR JAMES C | TenPercentOwner | 5 | 2018 | ||
| Borodkin Mark | Officer | Chief Operating Officer; CHIEF OPERATING OFFICER | 26 | 2018–2026 | |
| Cai Darren | Director | 3 | 2018–2019 | ||
| Cao Han PHD | Officer | Chief Scientific Officer | 3 | 2018 | |
| DOMAIN ASSOCIATES | TenPercentOwner | 1 | 2018 | ||
| Domain Partners VIII, L.P. | TenPercentOwner | 2 | 2018 | ||
| DOVEY BRIAN H | TenPercentOwner | 5 | 2018 | ||
| DP VIII Associates, L.P. | TenPercentOwner | 2 | 2018 | ||
| Halak Brian K | TenPercentOwner | 5 | 2018 | ||
| Holmlin R. Erik | Director,Officer | President and CEO; PRESIDENT AND CEO | 20 | 2018–2026 | |
| Kamdar Kim P. | TenPercentOwner | 1 | 2018 | ||
| LC Fund VI, L.P. | TenPercentOwner | 2 | 2018 | ||
| LC Healthcare Fund I, L.P. | TenPercentOwner | 1 | 2018 | ||
| LC Parallel Fund VI, L.P. | TenPercentOwner | 2 | 2018 | ||
| Luderer Albert | Director; Director,Officer | Interim Chief Executive | 13 | 2018–2026 | |
| Robinson Warren | Officer | Chief Commercial Officer | 4 | 2018–2020 | |
| TREU JESSE I | TenPercentOwner | 4 | 2018 | ||
| TWOMEY CHRISTOPHER J | Director | 15 | 2018–2026 | person page Fuzzy | |
| VITULLO NICOLE | TenPercentOwner | 5 | 2018 | ||
| WANG JUNFENG | Director,TenPercentOwner | 4 | 2018–2019 | ||
| Ward Michael James | Officer | Chief Financial Officer; Former Chief Financial Officer | 3 | 2018–2020 | |
| Zhou Quan | Director,TenPercentOwner | 4 | 2018–2019 | ||
| Rosy Shine Ltd | TenPercentOwner | 2 | 2018 | ||
| Wealth Strategy Holding Ltd | TenPercentOwner | 1 | 2018 | ||
| Vuori Kristiina MD | Director | 11 | 2019–2026 | ||
| Adams Heather | Officer | Chief Administrative Officer | 2 | 2020 | |
| Linney Yvonne | Director | 12 | 2020–2026 | ||
| Mamuszka Hannah | Director | 11 | 2020–2025 | ||
| Chaubey Alka | Officer | Chief Medical Officer; CHIEF MEDICAL OFFICER | 18 | 2020–2026 | |
| Stewart Christopher P. | Officer | Chief Financial Officer | 10 | 2020–2023 | |
| Priar Robert J | Officer | Chief Commercial Officer | 2 | 2021 | |
| Shippy Richard | Officer | Chief Business Officer | 3 | 2021–2022 | |
| Shams Soheil | Officer | Chief Informatics Officer | 5 | 2021–2022 | |
| Wong Vincent Jung-Fai | Director | 5 | 2021–2024 | ||
| Rajkovic Aleksandar | Director | 7 | 2022–2026 | ||
| Dixon Jonathan V. | Officer | General Counsel; GENERAL COUNSEL | 11 | 2023–2026 | |
| Kama Gulsen | Officer | Chief Financial Officer | 3 | 2023–2024 | |
| Adamchak Mark | Officer | Principal Accounting Officer | 10 | 2024–2026 | |
| Hastie Alex Reid | Officer | Chief Scientific Officer | 3 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-07-10 | Bionano Genomics, Inc. | Biotechnology | $20,000,001 | $20,000,001 | 2 | 1 |
| 2024-06-05 | Bionano Genomics, Inc. | Biotechnology | $20,000,000 | $20,000,000 | 4 | 1 |
| 2023-10-27 | Bionano Genomics, Inc. | Other Health Care | $35,000,000 | $35,000,000 | 1 | 1 |
| 2021-10-25 | Bionano Genomics, Inc. | Other Health Care | $41,850,386 | $41,850,386 | 27 | 1 |
| 2019-03-28 | Bionano Genomics, Inc | Pharmaceuticals | $11,500,000 | $2,500,000 | 3 | 1 |
| 2015-01-27 | BioNano Genomics, Inc | Pharmaceuticals | $68,443,451 | $68,443,451 | 17 | 1 |
| 2014-06-27 | BioNano Genomics, Inc | Pharmaceuticals | $6,139,997 | $5,000,500 | 5 | 1 |
| 2014-01-08 | BioNano Genomics, Inc | Pharmaceuticals | $15,000 | $15,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | BIONANO GENOMICS INC | CA | State business registries | name and state |
| Federal award recipient | BIONANO GENOMICS, INC | CA | Federal spending (USAspending) | name and state |
| Form D issuer | Bionano Genomics, Inc. | CA | Form D private offerings | CIK (EXACT) |
| Patent assignee | BIONANO GENOMICS, INC. | CA | Patents (USPTO) | name and state |
| SEC filer | Bionano Genomics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | BioNano Genomics, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | BIONANO GENOMICS, INC. | EIN (EXACT) | ||
| Person page | Christopher J Twomey | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Laboratory Analytical Instruments, CA first:
- NGEN, INC. CA
- CEPHEID CA
- LJL BIOSYSTEMS INC CA
- AGILENT TECHNOLOGIES, INC. CA
- ILLUMINA, INC. CA
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CA
- QPC Lasers CA
- WaferGen Bio-systems, Inc. CA
- PROTEINSIMPLE CA
- AutoGenomics, Inc. CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Laboratory Analytical Instruments · Technology